Neovacs S.A EV/Sales
What is the EV/Sales of Neovacs S.A?
The EV/Sales of Neovacs S.A. is N/A
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Health Care sector on EURONEXT compared to Neovacs S.A
What does Neovacs S.A do?
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Companies with ev/sales similar to Neovacs S.A
- News Invest has EV/Sales of N/A
- Tlou has EV/Sales of N/A
- Lustrum Minerals has EV/Sales of N/A
- HAW Capital 2 has EV/Sales of N/A
- Exore Resources has EV/Sales of N/A
- ESG Global Impact Capital has EV/Sales of N/A
- Neovacs S.A has EV/Sales of N/A
- Savara Inc has EV/Sales of N/A
- Coppermoly has EV/Sales of N/A
- GobiMin has EV/Sales of N/A
- JPMorgan Russian Securities Plc has EV/Sales of N/A
- Workhorse Inc has EV/Sales of N/A
- NGX International has EV/Sales of N/A